국립부경대학교 과학컴퓨팅학과

이학사 / 부산대학교 수학과

2018.10-2019.08

규슈대학교 생물학과 박사후 연구원 (일본)

2019.09-2021.03.

규슈대학교 생물학과 특임조교 (일본)

2021.04-2022.03

나고야대학교 생명과학과 특임강사 (일본)

2022.04-현재

부경대학교 조교수

 M. Yoshida, Y. Kobashi, T. Kwawamura, Y. Shimazu, Y. Nishikawa, F. Omata, T. Zhao, C. Yamamoto, Y., Kaneko, A. Nakayama, M. Takita, N. Ito, M. Kawashima, S. Sugiura, S. Iwami, K.S. Kim, S. Iwanami, T. Kodama and M. Tsubokura, Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survery, Vaccines, 10(4):515 (2022).

K. Matsuda, S. Islam, T. Takada, K. Tsuchiya, B.J. Yang Tan, S. Hattori, H. Katsuya, K.Kitagawa, K.S. Kim, M. Matsuo, K. Sugata, N.S. Delino, H. Gatanaga, K.Yoshimura, S. Matsushita, H. Mitsuya, S. Iwami, Y. Satou, and K. Maeda. Awidely distributed HIV-1 provirus elimination assay to evaluatelatency-reversing agents in vitro, Cell ReportsMethods, 1(8):100122 (2021).

K. S. Kim†, S. Iwanami†, T. Oda, Y.Fujita, K. Kuba, T. Miyazaki, K. Ejima‡, S. Iwami‡. Incomplete viraltreatment may induce longer durations of viral shedding during SARS-CoV-2infection, Life Science Alliance, 10:e202101049(2021). (†,‡Equalcontribution)

Y. D. Jeong†, K. Ejima†, K. S. Kim†, S. Iwanami, A.I. Bento, Y. Fujita, I. H. Jung, K. Aihara, K. Watashi, T. Miyazaki, T. Wakita,S. Iwami, M. Ajelli. Revisiting the guidelines for ending isolation forCOVID-19 patients, eLife, 10:e69340 (2021). (†Equalcontribution)

S. Iwanami†, K. Ejima†, K.S. Kim,K. Noshita, Y. Fujita, T. Miyazaki, S. Kohno, Y. Miyazaki, S. Morimoto, S.Nakaoka, Y. Koizumi, Y. Asai, K. Aihara, K. Watashi, R. N. Thompson, K.Shibuya, K. Fujiu, A.S. Perelson‡, S. Iwami‡, T. Wakita.Detection of significant antiviral drug effects on COVID-19 with reasonablesample sizes in randomized controlled trials: a modeling study combined withclinical data, PLOS Medicine, 18(7):e1003660(2021). (†,‡Equalcontribution)

K Ejima†, K. S. Kim†, S Iwanami†, Y Fujita, M Li,RS Zoh, K Aihara, T Miyazaki, T Wakita and S Iwami. Time variation in theprobability of failing to detect a case of PCR testing for SARS-CoV-2 asestimated from a viral dynamics model, Journal of theRoyal Society Interface, 18: 20200947 (2021). (†Equalcontribution)

H Ohashi†, K Watashi†, W Saso†, K Shionoya, SIwanami, T Hirokawa, T Shirai, S Kanaya, Y Ito, K. S. Kim, T Nomura, TSuzuki, K Nishioka, S Ando, K Ejima, Y Koizumi, T Tanaka, S Aoki, K Kuramochi,T Suzuki, T Hashiguchi, K Maenaka, T Matano, M Muramatsu, M Saijo, K Aihara, SIwami, M Takeda, JA McKeating, T Wakita. Potential anti-COVID-19 agents,Cepharanthine and Nelfinavir, and their usage for combination treatment, iScience, 24(4):102367(2021). (†Equal contribution)

K. Ejima†, K.S. Kim†, C. Ludema, A.I.Bento, S. Iwanami, Y. Fujita, H. Ohashi, Y. Koizumi, K. Watashi, K. Aihara, H.Nishiura, and S. Iwami. Estimation of the incubation period of COVID-19 usingviral load data, Epidemics, 35:100454(2021). (†Equal contribution)

K.S. Kim†, K. Ejima†, S. Iwanami, Y.Fujita, H. Ohashi, Y. Koizumi, Y. Asai, S. Nakaoka, K. Watashi, K. Aihara, R.N.Thompson, R. Ke, A.S. Perelson‡ and S. Iwami‡. A quantitativemodel used to compare within-host SARS-CoV-2, MERS-CoV and SARS-CoV dynamicsprovides insights into the pathogenesis and treatment of SARS-CoV-2, PLOS Biology, 19(3):e3001128.(2021). (†,‡Equalcontribution)

K.S. Kim†, T. Kondoh†, Y. Asai, A.Takada, S. Iwami, Modeling the efficiency of filovirus entry into cells invitro: Effects of SNP mutations in the receptor molecule, PLoS ComputationalBiology, 16(9):e1007612 (2020). (†Equalcontribution)

T. Oda, K.S.Kim, Y. Fujita, Y. Ito, T. Miura, S. Iwami, Quantifying antiviral effectsagainst simian/human immunodeficiency virus induced by host immuneresponse, Journal of Theoretical Biology, 110493 (2020).

K.S. Kim†, Y. Yamamoto, S.Nakaoka, K. Tomonaga, S. Iwami†, T. Honda,Modeling Borna disease virus in vitro spread reveals the mode of antiviraleffect conferred by an endogenous bornavirus-like element, Journal of Virology, JVI.01204-20(2020).

T. Kurusu†, K.S. Kim†, Y. Koizumi†, S. Nakaoka, K.,Ejima, N. Misawa, Y. Koyanagi, K. Sato, S. Iwami, Quantifying the antiviraleffect of APOBEC3 on HIV-1 infection in humanized mouse model, Journal ofTheoretical Biology, 498:110295 (2020). (†Equalcontribution)

K.S. Kim, M. Ibrahim, I. H. Jung, S. Kim, Mathematical analysis of the effectiveness ofcontrol strategies to prevent the autorun virus transmission propagation, Applied Mathematicsand Computation, 371:124955 (2020).

Y. D. Jeong, K.S.Kim, I. H. Jung, Optimal control strategies depending on interest level forthe spread of rumor, Discrete Dynamics in Nature and Society, 2018 (2018).

K.S. Kim, S. Kim, I. H. Jung, Hopf bifurcation analysis and optimal control of treatmentin a delayed oncolytic virus dynamics, Mathematics andComputers in Simulation, 149:1-16 (2018).

K.S. Kim, G. Cho, L. Nie, I. H. Jung, State-dependent impulsive control strategies for atumor-immune model, Discrete Dynamics in Nature and Society, 2016 (2016).

K.S. Kim,S. Kim, I. H. Jung, Dynamics of tumor virotherapy: A deterministic andstochastic model approach. Stochastic Analysis and Application, 34(3):483-495(2016).

K.S. Kim, G. Cho, I. H. Jung, Optimal treatment strategy for a tumor model under immunesuppression, Computational and Mathematical Methods in Medicine, 2014 (2014).